Evidence map›Paper›PMID 33446519›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

From Circuits to Chromatin: The Emerging Role of Epigenetics in Mental Health.

Philipp Mews, Erin S Calipari, Jeremy Day, Mary Kay Lobo, Timothy Bredy, Ted Abel

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The double-edged sword of the double-stranded break.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Philipp MewsFriedman Brain Institute, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York 10129 philipp.mews@mssm.edu.ORCID 0000-0003-2052-1578
Erin S CalipariDepartments of Pharmacology, Molecular Physiology and Biophysics, Psychiatry and Behavioral Sciences; Vanderbilt Center for Addiction Research; Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee 37323.ORCID 0000-0003-4723-0623
Jeremy DayDepartment of Neurobiology, McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, Alabama 35294.ORCID 0000-0002-7361-3399
Mary Kay LoboDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.ORCID 0000-0002-9419-2079
Timothy BredyQueensland Brain Institute, University of Queensland, Brisbane, 4072, Australia.ORCID 0000-0003-3280-126X
Ted AbelDepartment of Neuroscience and Pharmacology, Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa 52242.ORCID 0000-0003-2423-4592
Allen Institute for Brain Science · USThe University of Queensland · AUUniversity of Alabama at Birmingham · USUniversity of Iowa · USUniversity of Maryland, Baltimore · USVanderbilt University · US

Funding

Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YASMIN L. HURD · 2019 to 2026
$16.5M
Epigenetic Mechanisms of Memory StorageR01MH087463 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ABEL, EDWIN TED G. · 2010 to 2025
$7.8M
MOLECULAR STUDIES OF COCAINE ACTION IN BRAINR37DA007359 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1996 to 2020
$6.9M
Molecular Studies of Cocaine Action in BrainR01DA007359 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1991 to 2025
$5.6M
Cocaine-induced mitochondrial mechanisms and molecular mediators in reward circuitryR01DA038613 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LOBO, MARY KAY · 2014 to 2025
$4.9M
Mechanisms of dopaminergic dysfunction in substance use disorderR01DA052317 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2021 to 2025
$2.4M
Making and breaking opioid memories to prevent relapseDP1DA048931 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2019 to 2023
$2.4M
Epigenetic Control of Brain Reward SystemsDP1DA039650 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2015 to 2019
$2.3M
Enhancer RNA Regulation of Experience-dependent Neuroepigenetic ProcessesR01MH114990 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2018 to 2022
$2.3M
Ventral pallidum molecular mediators in cocaine addictionR01DA047843 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LOBO, MARY KAY · 2019 to 2023
$2.2M
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747k
Epigenetic Regulation of Cocaine-Induced NeuroadaptationsR00DA034681 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2014 to 2016
$741k
NIAAA NIH HHS K99 AA027839NIDA NIH HHS DP1 DA039650NIDA NIH HHS DP1 DA048931NIDA NIH HHS K99 DA034681NIDA NIH HHS K99 DA042111NIDA NIH HHS P01 DA047233NIDA NIH HHS R00 DA034681NIDA NIH HHS R00 DA042111NIDA NIH HHS R01 DA007359NIDA NIH HHS R01 DA038613NIDA NIH HHS R01 DA047843NIDA NIH HHS R01 DA052317NIDA NIH HHS R37 DA007359NIMH NIH HHS R01 MH087463NIMH NIH HHS R01 MH114990
6 · The paper itself

Abstract

A central goal of neuroscience research is to understand how experiences modify brain circuits to guide future adaptive behavior. In response to environmental stimuli, neural circuit activity engages gene regulatory mechanisms within each cell. This activity-dependent gene expression is governed, in part, by epigenetic processes that can produce persistent changes in both neural circuits and the epigenome itself. The complex interplay between circuit activity and neuronal gene regulation is vital to learning and memory, and, when disrupted, is linked to debilitating psychiatric conditions, such as substance use disorder. To develop clinical treatments, it is paramount to advance our understanding of how neural circuits and the epigenome cooperate to produce behavioral adaptation. Here, we discuss how new genetic tools, used to manipulate neural circuits and chromatin, have enabled the discovery of epigenetic processes that bring about long-lasting changes in behavior relevant to mental health and disease.

Indexed as

AnimalsBrainChromatinEpigenesis, GeneticHumansMemoryMental HealthNerve NetSubstance-Related DisordersChromatinactivity-dependent gene regulationepigenomelncRNAmemory engramsubstance use disorder

Identifiers

PMID33446519
PMCPMC7880276
OpenAlexW3119298500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.